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Abstract
Background: Various microbial, inflammatory and immune signals regulate the activation of
dendritic cells (DC), determining their ability to interact with naïve T cells and to produce
cytokines that direct T cell development. In particular, CD40L and IL-1 cooperatively activate DC
to secrete high levels of IL-12. The immuno-stimulatory capacity of such DC is otherwise not welldefined prompting further characterization of the effects of IL-1 and family members on DC
activation in comparison with other pro-inflammatory stimuli.
Results: Human DC co-activated in vitro by CD40L and IL-1b expressed numerous cytokine genes
including IL-12b, IL-23 p19, IL-1b, IL-1a, IL-1Ra, IL-10, IL-6, IL-18 and IFN-g. These DC produced
high levels of IL-12 protein and appeared capable of producing IFN-g. Potent CD4+ and CD8+ T
cell-stimulatory properties were acquired by DC under conditions that also induced IL-12.
Notably, these DC induced rapid differentiation of fluMP-specific CD8+ T cells. Molecules related
to IL-1b, like IL-1a, co-induced IL-12 secretion whereas IL-18 did not. Conversely, the inhibitor IL1Ra, produced endogenously by DC curtailed IL-12 production in response to CD40L.
Conclusions: IL-1 and IL-1Ra play a biologically-relevant role in the positive and negative
regulation of DC activation. In conjunction with CD40L, IL-1 sends a powerful activation signal to
DC that could be distinguished from other modes of activation. This signal enables the production
of pro-inflammatory cytokines by DC, and enhances the differentiation of naïve T cells into
effectors of type-1 cellular immune responses.

Background
Dendritic cells (DC) are highly effective antigen presenting cells (APCs) capable of stimulating the differentiation
of naïve lymphocytes into effector cells (reviewed in [1]).
Specific properties of the DC determine the quality of im-

mune responses that they initiate. These properties are determined by complex and dynamic changes both in the
DC and in its environment. Notably, DC undergo a socalled process of maturation that changes migratory properties, diminishes antigen uptake, enhances antigen
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processing and presentation and induces the production
of an array of cytokines (reviewed in [2]). The qualitative,
quantitative and temporal regulation of cytokines produced by DC is thought to be a determining factor in the
development of immune responses initiated by these
APCs but molecules and mechanisms that regulate such
process are not entirely understood.
Activated T cells provide strong stimuli that activate cytokine production in DC notably via interactions between
CD40L and CD40 [3,4]. This interaction not only regulates the production of Th1 polarizing cytokines such as
IL-12 by DC in vitro but is a central event in vivo that enables DC to prime effective MHC class I-restricted CD8+ T
cell responses [5–7]. IL-12 is a pivotal factor for the initiation of cellular immunity (reviewed in [8]). IL-12 promotes the polarization of Th1 T cell development,
increases the differentiation and activation of cytolytic T
cells and in concert with IL-18, induces IFN-g production
by T cells and NK cells. The mechanisms regulating IL-12
production are complex as IL-12 is composed of two
chains IL-12a (IL-12p35) and IL-12b (IL-12p40) with independent transcriptional regulation. The two chains assemble as a disulfide-linked heterodimer which is
glycosylated and secreted as a biologically active pro-inflammatory and immune mediator [9,10]. CD40L is
known to induce the production of high levels of IL-12b
in human monocyte-derived DC [11]. Yet, signalling
through CD40 alone is not sufficient to induce the secretion of substantial amounts of IL-12ab heterodimer. We
and others have shown that a second signal, provided by
a microbial product (lipopolysaccharide=LPS) or by immune mediators such as IFN-g or IL-1b, is required to induce the secretion of high levels of IL-12 by DC in the
presence of CD40L [12–15].
IL-1 is major pro-inflammatory cytokine with multiple activities in the regulation of immune, inflammatory, endocrine and neuronal systems (reviewed in [16]). The IL-1
family comprises several structurally-related ligands and
the most extensively characterized include IL-1a, IL-1b,
the inhibitory IL-1 receptor antagonist (IL-1Ra) and IL-18
(IL-1g). These ligands bind to members of a family of receptors characterized by immunoglobulin folds in the extracellular portion and Toll/IL-1R (TIR) motif in the intracytoplasmic portion [17]. Whereas ligands of Toll-like receptors such as LPS and other microbial products have recently gained a lot of attention as regulators of immune
responses in general (reviewed by [18]) and of DC activation in particular [19], ligands of IL-1R family have not
been as extensively examined under this angle. On its
own, IL-1 is known to be a weak maturing agent for DC
[4]. However, we have recently shown that when combined with CD40L, IL-1b sends a powerful cooperative
signal to monocyte-derived DC, inducing the secretion of
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high levels of IL-12 [14]. This was recently confirmed and
extended to show that IL-1b and CD40L also induce the
secretion of high levels of IL-12 in CD34+ cell-derived DC
[15] and A. Wesa, unpublished observation), and that this
mode of activation also triggers the production of high
levels of IL-6 and the production of IL-1. The effects of IL1 can be explained at least at the transcriptional level, as
CD40L up-regulates IL-12b mRNA and IL-1b complements this effect by up-regulating IL-12a mRNA [14]. Our
own results suggest that CD40L co-activation with IL-1b
yields high amounts of IL-12 but little IL-10 whereas LPS
induces IL-12 but also more IL-10 [14]. As DC encounter
various innate, microbial or immune stimuli that engage
distinct intracellular signaling pathways, it seems likely
that various combinations of these modes of activation
might not produce equivalent APCs. The immuno-stimulatory properties of DC activated with IL-1 and C40L have
not been well-defined and it is not clear that these cells
which produce high amounts of IL-12 will be able to
prime and activate naive T cells, in particular CD8+ T cells.
This prompted the present study to better characterize the
effects of IL-1 and to better understand the molecular regulation of DC function. We found that CD40L+IL-1b
stimulation effectively confers immuno-stimulatory activity and could be distinguished from other modes of proinflammatory activation of DC. We also found that the
constitutive expression of IL-1Ra in DC constitutes a regulatory mechanism curtailing DC activation in the absence
of specific inflammatory signals suggesting that the family
of IL-1 molecules has biological relevance to DC activation.

Results
Regulation of cytokine gene expression in DC
Cytokine gene expression in human monocyte-derived
DC was analyzed in response to various pro-inflammatory stimuli. Immature DC were produced by culture of adherent blood monocytes with GM-CSF and IL-4 and these
cells were matured by treatment with CD40L combined
with either IL-1b or IFN-g or for comparison by treatment
with LPS+IFN-g effective inducers of IL-12 in DC [12]. The
expression of IL-12a, IL-12b, IL-10, IL-1a, IL-1b, IL-1Ra,
IL-6, IL-18, IFN-g and the housekeeping L32 and GAPDH
genes were assessed using a non-isotopic multiple probe
RPA. Levels of mRNAs were calculated in relation to
housekeeping gene expression. Results from 2 to 7 independent experiments are presented in Figure 1. Treatment
with CD40L+IL-1b induced the expression of multiple
genes as IL-12b, IL-10, IL-1a, IL-1b, IL-6, IL-18 and IFN-g
were more highly expressed than in DC untreated or treated with IL-1b alone. The conjunction of CD40L with either IL-1b or IFN-g induced statistically higher levels of IL12b than CD40L alone (8.00 ± 4.0 with CD40L+IL-1b or
5.68 ± 1.6 with CD40L+IFN-g; versus 1.53 ± .0.5 for
CD40L alone; p < 0.05). However, these two co-stimulato-
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Figure 1
Comparison of different activation signals on gene
expression in DC. Normalized gene expression levels from
2–7 independent experiments with averages indicated by a
horizontal bar. DC were cultured with LPS+IFN-g (n = 2);
CD40L+IFN-g (n = 3); CD40L+IL-1b (n = 7); CD40L (n = 7);
IL-1b (n = 4); medium n = 4 for 8 hours and total RNA was
extracted and hybridized to biotin-labeled RNA probes.
After RNase treatment, digested probes were separated on a
5% acrylamide/8 M urea gel, blotted to a positively charged
membrane for detection with CDP-Star substrate solution,
and exposed to film or directly to the Kodak Image Station.
Controls include yeast RNA incubated with probes followed
or not by RNase treatment. Relative gene expression levels
were calculated by dividing the net intensity of a gene (calculated with Kodak 1D software) with the net intensity of L32
in the same lane.

ry signals had distinct effects. Treatment with
CD40L+IFN-g induced IL-12b, IL-1a, IL-1b, and low levels
of IL-18 but no IL-6, IL-10 or IFN-g. Statistical analysis
confirmed that DC treated with CD40L+IFN-g produced
significantly less IL-6, IL-10 and IL-1b than DC treated
with CD40L+IL-1b (p < 0.05, n = 3). This difference was
confirmed over time in kinetics studies examining gene
expression at 4, 8 and 16 hours post-stimulation (data not
shown). The overall strongest induction of gene expression was obtained by treatment with LPS+IFN-g (Figure 1)
which was uniquely able to induce high levels of IL-12a
mRNA by RPA. Furthermore, IL-1Ra mRNA was upregulated in response to LPS+IFN-g whereas it remained relatively constant with all other stimuli.
As DC respond to complex signals including autocrine signals such as IL-1b and IFN-g, it seemed imperative to analyze how these complex combinations regulate gene
expression in comparison with a strong pro-inflammatory
activator such as LPS. Combinations of CD40L, IFN-g, LPS
and IL-1b were therefore compared (Figure 2). Each of the
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Figure 2
Effect of combined signals on cytokine gene expression in DC. DC (1 ´ 106) were treated with CD40L+IL-1b,
CD40L+LPS, LPS+IL-1b, LPS+CD40L+IL-1b, CD40L+IFN-g
or LPS+IFN-g for 8 hours. Following stimulation, RNA was
isolated and subjected to RPA analysis (as described in Figure
1). Controls are shown of yeast RNA incubated with probes
followed by RNase treatment (background) or mock treatment (undigested probes).

combination tested induced the production of IL-12b and
the overall transcription profiles examined appeared to be
qualitatively similar. However, the presence of LPS clearly
correlated with higher levels of IL-12a and IL-10 mRNAs.
Thus, DC treated with CD40L+IL-1b induced gene expression patterns that were qualitatively similar to those induced by LPS+CD40L, LPS+IL-1b or LPS+CD40L+IL-1b
but qualitatively distinct from those induced by
CD40L+IFN-g. This transcriptional analysis implies that
activation of DC by diverse pro-inflammatory agents may
have distinct functional outcome.
Regulation of IL-12 and IL-23 secretion in DC
We previously reported that IL-12 ab heterodimer was being secreted after stimulation with IL-1b+CD40L [14]. To
verify these findings, supernatants of DC were immunoprecipitated with a mAb against IL-12b and separated by
non-reducing SDS-PAGE. Detection with a mAb specific
for IL-12a/b heterodimer (Figure 3-A) confirmed that
CD40L+IL-1b, LPS+IFN-g, and CD40L+IFN-g induced the
secretion of the 70 kD heterodimer IL-12ab at levels correlated to those detected by ELISA (data not shown).
These data confirmed the synergy of CD40L+IL-1b+IFN-g
on the secretion of IL-12a/b. The secretion of the 70 kD
IL-12 was further confirmed by blotting the immuno-precipitants with a polyclonal IL-12 Ab (Figure 3-B). This polyclonal Ab also revealed the secretion of free IL-12b at 40
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Production of IFN-g by DC
RPA studies indicated that IFN-g mRNA was induced after
stimulation of DC with CD40L+IL-1b, CD40L+LPS or
LPS+IFN-g (Figures 1 and 2). Production of IFN-g has
been reported in murine DC [21] but not to our knowledge in human DC. To verify these findings, we analyzed
the production of IFN-g and IL-12b in DC by flow cytometry. Results of 4 separate experiments showed the presence of intracellular IFN-g as demonstrated by staining
levels above isotype-matched controls in cells of large
size, expressing HLA-DR or CD1a but lacking CD3 or
CD56 (Figure 4 and not shown). Under these conditions,
DC cultured in medium or with LPS or LPS+IL-1 did not
express significant levels of IFN-g (data not shown), thus
arguing in favor of a specific response. Co-staining for
IFN-g and IL-12p40 further showed that a subset of human monocyte-derived DC could produce both cytokines. Statistical analysis showed that DC stimulated
with CD40L or CD40L+IL-1b (respectively containing 3.4
± 2.5 % and 3.9 ± 2.8 % cells expressing IFN-g) produced
significantly more IFN-g than control DC (0.08 ± 0.1 %),
p < 0.05. This is consistent with mRNA data shown in Figure 1.

18S RNA

Figure 3
CD40L+IL-1b-treated DC secrete IL-12 and IL-23
heterodimersA-B. Immature DC were stimulated for 24
hours with LPS+IFN-g, CD40L+IFN-g, CD40L+IL-1b+IFN-g,
CD40L or CD40L+IL-1b. Supernatants and control AIM-V
medium were concentrated by centrifugation, then subject to
immunoprecipitation with anti-IL-12p40/p70 monoclonal
antibody (clone C8.6, PharMingen) and A/G agarose beads.
Immunoprecipitants were separated by 10% SDS PAGE
under non-reducing conditions. A. Detection of IL-12p70
using IL-12p70-specific rat mAb 20C2 (PharMingen). B.
Detection using anti-IL-12 polyclonal goat Ab (R&D Systems). C. RT-PCR analysis for p19 and 18s RNA. DC were
stimulated with indicated stimuli for 8 h. Total RNA was
extracted, reverse-transcribed and used as template for
amplification during 35 cycles. Results show ethidium bromide detection of PCR products on agarose gel (represents
one of 3 separate experiments).

kD in all conditions tested and the presence of a 60 kD
complex in some conditions (arrow). It is very likely that
this 60 kD complex formed between IL-12b (40 kD) and
the recently described p19 subunit chain form the IL-23
heterodimer [20]. RT-PCR confirmed that p19mRNA was
found in DC stimulated with CD40L and IL-1 (Figure 3C) and the detection of IL-23 in CD40L-activated DC is
consistent with prior reports [20]. Interestingly, immunoprecipitation studies suggest that the IL-23 60 kD complex
is produced at a higher level upon treatment with
CD40L+IL-1b+IFN-g.

Regulation of cytokine production by molecules related to
IL-1
IL-1b, like other ligands of TLR/IL1R (LPS or peptidoglycan) [19] is able to co-induce the secretion of IL-12
prompting us to ask if signaling through the IL-1R superfamily could represent a general mechanism for the induction of IL-12 in DC. Like IL-1b, IL-1a acted in
combination with CD40L to increase the secretion of IL12 in a dose-dependent manner (Figure 5-A). Comparable
dose-response curves were obtained with IL-1a and IL-1b
which at doses of 10 ng/ml co-induced the secretion of
14.9 ± 3.8 and 13.0 ± 4.3 pg IL-12/1000 cells, respectively,
while CD40L alone induced 0.3 ± 0.4 pg IL-12/1000 cells
(n = 2). On the other hand, IL-18 showed no effect, even
at concentrations up to 500 ng/ml (Figure 5-A) as IL18+CD40L was not different from CD40L alone (1.12 ±
0.9 and 0.4 ± 0.3 pg/1000 cells respectively, n = 2). While
IL-1a and IL-1b share the same signal-transmitting receptor complex of IL-1RI and IL-1R3, IL-18 engages a distinct
receptor complex IL-1R5/IL-1R7 [17,22]. The expression
of IL-18R was undetectable on DC by flow cytometry, although it was found on the surface of activated T cells (data not shown). The lack of responsiveness by DC to IL-18
appears to be due to the lack of IL-18R expression on
monocyte-derived DC.

Both unstimulated DC and activated DC constitutively expressed IL-1Ra mRNA. This IL-1 family member negatively regulates IL-1 by competitively binding to IL-1RI
without inducing the signaling cascade (reviewed in [23]).
This suggested that IL-1Ra could perturb the effects of IL-
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Figure 4
Production of IFN-g by human monocyte-derived DC
DC were treated with CD40L (top left panel) or CD40L+IL1b (top right panel) for 24 hours, monensin being present
during the last 5 hours of incubation. After staining for surface markers and intracellular IFN-g, DC were analyzed by
flow cytometry. Large CD3- cells were analyzed (as shown in
gate represented in bottom left dot-plot) to exclude T cells,
and results show staining above isotype control (bottom
right dot-plot), being expressed as percentages of CD1a+
cells expressing IFN-g. Result representative of 4 experiments.

1 signaling in DC and could impact on the regulation of
IL-12 production. Figure 5-B shows a representative experiment with the specific inhibition of IL-1Ra by neutralizing antibodies. Anti-IL-1Ra Ab significantly increased the
secretion of IL-12 induced by CD40L relative to DC treated with control IgG and CD40L (4.65 ± 3.7 and 0.85 ± 0.7
respectively; p < 0.02, n = 3). The neutralizing anti-IL-1Ra
antibody did not affect the production of IL-12 when DC
were activated with medium or IL-1b alone which is consistent with the fact that these conditions do not up-regulate IL-12b on their own. The neutralizing antibody also
did not affect the levels of IL-12 produced in response to
CD40L+IL-1b. In this case, the exogenous IL-1 provided
maximal induction of IL-12 and was probably largely in
excess of the endogenous IL-1Ra, therefore inhibition of
IL-1Ra did not provide additional induction of IL-12. Altogether, these results provide evidence that both IL-1Ra
mRNA and IL-1 mRNA are translated in CD40L-treated
DC, and act in a biologically relevant manner. Further,
this demonstrates that constitutive IL-1Ra expression regulates the response of DC to endogenous IL-1.
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Figure 5
Effects of IL-1 family membersA, IL-12 secretion is
modulated by IL-1a or IL-1b, but not by IL-18. Human
monocyte-derived DC were treated with CD40L (1 mg/ml)
for 24 hours in the presence of increased concentrations of
IL-1a, IL-1b or IL-18 (0 to 100 or 500 ng/ml). Secreted IL-12
heterodimer was measured in supernatants by ELISA. B,
Blocking IL-1Ra increases CD40L-induced secretion of IL-12
heterodimer. DC were activated as indicated in the presence
of either anti-IL-1Ra neutralizing Ab or normal goat IgG for
24 hours. Supernatants were harvested and analyzed for IL12 heterodimer by ELISA. The average secretion in duplicate
wells was calculated as pg/1000 cells. Results are representative of three experiments. * indicates statistical significance of
anti-IL-1Ra Ab treatment.

DC stimulated by CD40L+IL-1b effectively prime and stimulate the differentiation of CD4+ and CD8+ T cells
DC treated with CD40L+IL-1b produced high levels of
pro-inflammatory cytokines such as IL-12 and IL-23 that
are known to augment T cell activation but also produce
inhibitory molecules such as IL-10 or IL-1Ra with opposite effects. To assess the net outcome of this stimulation,
T cell-stimulating properties of these DCs were examined
using priming of naïve cord blood CD8+ T cells to the
HLA-A2-restricted fluMP peptide. The detection of fluMPspecific cells in culture was done by flow cytometry using
Flu-MP-HLA-A2 tetramers. DC activated with CD40L+IL1b appeared to prime more effectively than DC activated
with CD40L or than immature DC (Table 1 and Figure 6A). Absolute numbers of tetramer-positive cells induced
by CD40L+IL-1b-primed DC are significantly higher than
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CD40L+IL-1b stimulated DC induce high levels of
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cell priming was assessed by measuring IFN-g producing cells
with flow cytometry after a brief restimulation on anti-CD3/
anti-CD28 coated plates. Data represent results of three
independent experiments.

0

Flu-MP tetramer APC
Figure 6
CD40L+IL-1b stimulated DC are highly effective
APCs for CD8+ T cell priming. HLA-A2+ cord bloodderived immature DC were treated with CD40L+IL-1b,
CD40L or medium for 16 hours, pulsed with Flu-MP peptide,
washed and used to prime naïve autologous T cells. On day
7, T cell cultures were analyzed for the presence of antigenspecific CD8+ T cells using Flu-MP-HLA-A2 tetramers. Representative dot plots are shown of CD8 vs. Flu-MP tetramer
(A), and CD45RA vs. Flu-MP tetramer (gated on CD8+ cells)
(B). All were gated on live, PI- cells; quadrants were set
based on background staining with control mAbs. Percent
positivity is indicated in corresponding quadrants.

in cultures primed by CD40L-activated DC (p < 0.05, t
test). These enhancing effects of CD40L + IL-1 over
CD40L were blocked by polyclonal Abs to IL-12 recognizing IL-12b-associated proteins suggesting that the enhanced production of IL-12 and/or IL-23 is responsible
for this activity (Table 1, experiment 4). Strikingly, peptide presentation by DC matured with CD40L+IL-1b induced the rapid differentiation of antigen-specific cells as
seen by the presence of Flu-MP-HLA-A2high CD45RACD8+ T cells (Figure 6-B). This was confirmed at day 14
post priming (data not shown). Induction of allogeneic
responses was examined by measuring the production of
IFN-g in MLR. Naïve cord blood CD4+ or CD8+ T cells or
adult blood T cells produced more IFN-g when primed
with DC treated with CD40L+IL-1b than with DC treated
with CD40L alone or IL-1b alone (Figure 7). Thus, these
DC are highly effective and functional APCs that act in a

manner consistent with the production of high levels of
pro-inflammatory cytokines such as IL-12, IL-23, IL-18
and IFN-g that are known to activate CD4+ and CD8+ T
cells and cellular immunity in general.

Discussion
We herein show that various pro-inflammatory molecules
can generate distinct activation profiles in DC and that
members of the IL-1 family of proteins play a biologically
relevant role in the regulation of the functional differentiation of DC.
Multiple activation signals appear to be required to induce the production of high levels of cytokines by DC.
The production of IL-12 which is a pivotal event in the development of type-1 cellular immunity is effectively induced in vitro by treating DC with CD40L+IL-1b and even
more so by CD40L+IL-1b+IFN-g, in agreement with recent
findings by Luft et al. [15]. Such synergistic concept is consistent with in vivo studies showing the dependence on
both microbial signals and endogenous CD40L to induce
effective immunity [13]. Exposure to multiple pro-inflammatory mediators is likely to occur under biological circumstances as these mediators can be transcriptionally
induced in a contemporary manner and are regulated by
autocrine loops, commonly described in inflammation
[24]. In combination with CD40L, IL-1 induces the production of IL-12, IL-1, IFN-g and IL-18 in DC. IL-18, acting
in combination with IL-12 could induce large amounts of
IFN-g by lymphocytes, further sensitizing DC to produce
extremely high levels of IL-12. The role played by DC-derived IFN-g remains unclear. Neutralization studies suggest that IFN-g is not responsible for IL-12 production in
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Table 1: Effects of DC activation on priming of CD8 + T cell responses

Exp. (a)

DC used in priming (b)

Percent of CD8+ cells binding
Flu-MP-HLA-A2 tetramer

Absolute number of
Flu-MP specific cells

Fold expansion Flu-MP
specific T cells

1

CD40L + IL-1b
CD40L
Immature

2.39
1.68
0.84

5020
2900
1190

Not determined
"
"

2

CD40L + IL-1b
CD40L
Immature

0.28
0.24
0.25

1400
528
656

7.0
2.6
3.3

3

CD40L + IL-1b
CD40L
Immature

0.26
0.14
0.00

594
309
0

2.9
1.5
0

4

CD40L + IL-1b
CD40L
Immature
CD40L + IL-1b
CD40L
Immature

1.39
0.64
0.61
0.57
0.78
0.41

2870
945
1130
1270
1200
700

19.1
6.3
7.5
8.5
8.0
4.7

IgG
"
"
Anti-IL-12
"
"

(a) Neonatal umbilical cord blood was used for exp. 1–3, adult mobilized peripheral blood was used in exp. 4. (b) Monocyte-derived DC cultured in
GM-CSF+IL-4 were used as immature DC (unstimulated), or after activation with CD40L (1 ug/ml) or CD40L + IL-1b (1 ug/ml, 10 ng/ml respectively) for 24 hours. In experiment 4, polyclonal neutralizing Abs to IL-12 or normal goat IgG (1 mg/ml), were added at time of priming.

response to IL-1b and CD40L [14]. As IFN-g is produced
approximately 24 hours after stimulation it seems that its
role would be to contribute to T cell activation rather than
to DC activation itself. DC-derived IFN-g has been reported in the mouse [21], albeit under distinct activating conditions. Based on these studies it remains to be tested if
IFN-g production by human DC might also be indirectly
due to the presence of IL-12 and IL-18.
Here, we report distinct pro-inflammatory stimuli that all
induce high levels of IL-12 but appear to provide otherwise distinct responses. In contrast to IL-1, co-stimulation
with IFN-g induced relatively little IL-10, IL-6, IL-18 and
IFN-g. LPS induced higher IL-10, higher IL-1Ra and strikingly less IL-23. The difference in the ability to produce IL10 was confirmed at the protein level (data not shown
and [14]). While IL-12 is important for naïve CD4+ T cell
priming, IL-23 is reportedly important for memory CD4+
cells [20]. Differences between IL-12 and IL-23 production suggest that DC may display distinct cytokine profiles
that correspond to distinct phases of an immune response. Another interpretation is that DC may interpret
distinct pathogen signals, for instance IL-1 or LPS, to
mount different types of cytokine reponses [19,25,26].

This would be desirable to optimize host defense against
particular aggressions or to be effective in particular tissues. The biological consequences of these differences will
have to be determined in future studies.
An important aspect of the autocrine regulation of cytokines in DC is the production of negative regulators
such as IL1Ra. Genetic invalidation of IL-1Ra not only upregulates inflammation but also affects the immune system, causing spontaneous development of auto-immune
arthritis in certain strains of mice and rendering other
strains more susceptible to immunogens causing this disease [27]. The precise mechanisms underlying the role of
IL-1Ra in immune responses are complex, but implicate
antigen presentation. APCs of mice lacking IL-1Ra induce
higher proliferation and higher activation of wild-type
CD4+ T cells than control APCs, resulting in the up-regulation of CD40L, OX40 and IL-2Ra, and thus have the opposite effects of APCs lacking IL-1 [28]. Our own data
provide a potential mechanistic explanation clearly showing for the first time that IL-1Ra can have a direct role on
APC function by regulating the secretion of IL-12. Neutralization experiments in DC showed that IL-1Ra inhibited the secretion of IL-12 in response to CD40L. This is
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most likely through negative regulation of endogenous IL1 responses as well as CD40L-induced IL-1 in DC. While
the RPA technique did not reveal IL-1 transcripts in unstimulated immature DC, it has been reported that IL-1b
mRNA are detected by the more sensitive RT-PCR analysis
in freshly-isolated Langerhans cells, generally considered
a paradigm for unstimulated immature DC [29]. Furthermore, direct evidence of IL-1b protein secretion has been
shown in monocyte-derived DC [15]. This demonstrates
that autocrine cytokine regulation via IL-1 family members is a biologically relevant mechanism in DC. As IL-1Ra
appears to be a negative regulator of DC activation, it is
notable that the LPS+IFN-g stimulation induces the highest levels of IL-1Ra mRNA in DC. As high levels of IL-1a,
IL-1b are also induced, IL-1Ra may provide a negative balance to prevent the establishment of an IL-1-mediated autocrine stimulation cascade and to curtail the effects of
LPS. Thus, IL-1Ra may be one significant built-in mechanism in the APC to regulate its immuno-stimulatory properties and to prevent the development of uncontrolled
immunity. The biological relevance of these conclusions
seems further supported by genetic analyses studies in humans. Polymorphisms in the IL-1Ra gene such as the
IL1RN*2 allele cause quantitative differences in both IL1Ra and IL-1b production and associate with the severity
of inflammatory and auto-immune diseases such as ulcerative colitis and Crohn's disease, lupus erythematosus and
possibly with coronary artery disease. Conversely, these
polymorphisms negatively associate with various infections such as vaginal colonization with mycoplasmas, cytomegalovirus,
Epstein-Barr
virus,
human
immunodeficiency virus and with the occurrence of ovarian cancer (recently reviewed in [30]).
Our results therefore identify IL-1 as an effective co-activator of DC in conjunction with CD40L. This is consistent
with the fact that IL-1 has been recognized as an adjuvant
for almost 2 decades [31] and may refine our understanding of the effects of IL-1 in the context of DC-initiated immunity. Thus, IL-1 which is produced locally and
systemically in response to inflammation or infection
may play an important role as a T cell-independent factor
complementing the effects of T cell-derived CD40L. Upon
encountering these two molecules, DC would become
more effective APCs, producing IL-12, IL-23, IL-18 and
IFN-g and stimulating the differentiation of CD4+ and
CD8+ T cells. Besides implications in inflammatory, infectious or auto-immune diseases, our data are also consistent with the identification of IL-1 as an important
adjuvant of CTL immunization in vivo in conjunction with
IL-12, IL-18 or IFN-g [32]. Like IL-1, IL-12 is not critically
required for the generation of CTL, yet the addition of exogenous IL-12 or the inhibition of IL-12 respectively improve or inhibit the development of CTL [33,34]. Our
results confirm that IL-12 is not essential for priming
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against fluMP since neutralizing Abs do not block the development of specific T cells. However, we show that enhanced production of IL-12 or IL-23 by CD40L+IL-1activated DC mediates the enhancing effects on the priming of CD8+ T cell responses.

Conclusions
Altogether, we predict that CD40L+IL-1b-treated DC will
function as effective vaccines for the induction of cellular
immunity in vivo. As we see that various degrees of pro-inflammatory functional differentiation can be acquired by
DC, it seems that the rational use of adjuvants based on
molecular regulation of cytokines in DC may yield useful
vaccines for immunotherapy.

Methods
Source of cells
Human blood samples were obtained with approval from
the Institutional Review Board of Wayne State University.
G-CSF mobilized peripheral blood was obtained from
breast cancer patients at the Karmanos Cancer Institute.
Cord blood samples were obtained from Hutzel Hospital,
Detroit MI. Mononuclear cells (MNC) were isolated by
centrifugation over Ficoll (Amersham Pharmacia Biotech,
Piscataway, NJ) (d < 1.077 g/ml) and were cryopreserved
in liquid nitrogen using a 10% DMSO freezing solution.
Culture of DC
Monocytes were obtained by incubating MNC on tissue
culture plates (2 ´ 106 cells per ml per well in 24 well
plates) in RPMI medium with 10% fetal bovine serum
(FBS) (R10) [35] in a humidified atmosphere at 37°C, 5%
CO2 for 2 hours, followed by washing to remove non-adherent cells. These adherent cells were cultured in R10 medium with GM-CSF (25 ng/ml, Immunex, Seattle, WA),
and IL-4 (100 U/ml, kind gift from Dr. H Yssel, DNAX Research Institute, Palo Alto, CA) to induce DC differentiation.
DC activation
Following 6 days of culture, cells were harvested and
washed twice in cytokine-free medium, prior to incubation with stimuli such as: human recombinant CD40L
trimer (1 mg/ml; kind gift of Immunex), IL-1b (10 ng/ml,
unless stated otherwise; Biological Resource Branch Repository, Rockville, MD), LPS (100 ng/ml; Sigma, St. Louis MO), IFN-g (100 ng/ml; R&D Systems), IL-1a (various
concentrations; R&D Systems), IL-18 (various concentrations; R&D Systems), TNF-a (50 ng/m; RDI, Flanders, NJ).
To measure intracellular cytokine production, monensin
(2 mM; Sigma) was added to the DC culture for the last 5
hours. To measure cytokine secretion by ELISA, supernatants were collected after 24 hours and stored frozen at 20°C until tested. Endotoxin levels in working concentrations of cytokines, media and CD40L were determined to
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be less than 0.01 ng/ml by Limulus amoebocyte lysate gel
assay (Sigma).
Immuno-staining and flow cytometric analysis
Intracellular staining was done as previously described
[14], Briefly, after fixation in 4% formaldehyde, cells were
washed twice in PBS then permeabilized in saponin buffer
(0.1% saponin (Sigma), 0.2% BSA, 0.02% sodium azide,
in PBS). Non-specific Fc binding was blocked by incubation for 10 min. on ice with excess human gamma-globulin in saponin buffer (1 mg/ml; Gamimune, Miles,
Eckhert, IL), then cells were incubated for 30 minutes on
ice with mAbs diluted in saponin buffer followed by 2
washes in saponin buffer. Cells were resuspended in wash
buffer without saponin prior to analysis. FITC or APCconjugated anti-IL-12 (BD-PharMingen), which recognizes the IL-12 b-chain either alone or in IL-12 a/b heterodimer, was used for detection of intracellular IL-12b in
DC, while PE-conjugated anti-IFN-g (clone 4S.B3,
Pharmingen) were used for measuring intracellular IFN-g
by DC or T cells. Irrelevant control mAbs were used as negative controls of non-specific staining. Cells were analyzed
on a FACSCalibur instrument (Becton Dickinson) and
data were analyzed using WinMDI (Version 2.8) software.
ELISA
IFN-g was measured in supernatants using the OptEIA ELISA set for IFN-g according to manufacturer's instructions
(BD-PharMingen). The lower limit of detection was 4 pg/
ml.
Non-isotopic RNase protection assay (RPA)
Following activation with various stimuli for 8 hours (unless otherwise indicated), total RNA was isolated from DC
using RNA Isolator (Sigma-Genosys, The Woodlands, TX).
Biotin labeled RNA probes were transcribed from
PharMingen's Multi-Probe template set using Maxiscript
transcription kit (Ambion Inc., Austin, TX) withT7 RNA
polymerase and biotin-14-CTP (Gibco-BRL, Rockville,
MD) used at a 40:60 ratio with unlabeled CTP. RPAs were
performed using Ambion's RPA III kit according to manufacturer's instructions. Briefly, sample RNA was hybridized to 8 ng biotin-labeled probes overnight at 56°C, then
digested with RNase A/T. Digested probes were analyzed
on
a
8
M
urea/5%
polyacrylamide
gel
(19:1acrylamide:bis-acrylamide, (BioRad, Hercules, CA))
in TBE. Separated probes were transferred to a positively
charged nylon membrane by a semi-dry electroblotter
(Owl Separation Systems, Portsmouth, NH), UV crosslinked (Stratagene, La Jolla, CA), then subjected to chemiluminescent detection using Ambion's BrightStar Biodetect kit with CDP-Star substrate. Membranes were exposed
either to Kodak Biomax ML film, or directly to the Kodak
Image station 440 CF for a one-hour capture. Images analysis was performed using the Kodak Image station 440 CF
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and 1D Image Analysis software. Results are expressed as
the ratio of net signal intensity for a particular mRNA to
the net signal intensity of the L32 housekeeping gene.
Immunoprecipitation and western analysis
DC supernatants were concentrated by centrifugation
through YM-10 concentrators (Millipore Corp., Bedford,
Massachusetts) then immunoprecipitated with anti-IL12b (C8.6, PharMingen) and A/G agarose bead conjugates
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Precipitants were separated by 10% SDS-PAGE under non-reducing conditions, transferred to PVDF membrane, and
blotted with anti-IL-12p70-specific rat monoclonal Ab
20C2 (PharMingen) or anti-IL-12 goat polyclonal Ab
(R&D Systems). HRP-conjugated goat-anti-rat or donkeyanti-goat polyclonal secondary Abs were visualized using
the ECL detection system (Amersham Biosciences, Piscataway, NJ). Blots were exposed to Biomax ML film as
above.
Blocking with neutralizing antibodies
To examine the effects of IL-1ra on DC activation, goat
anti-human neutralizing IgG specific for IL-1Ra (R&D Systems) and normal goat IgG (R&D Systems) were added at
the start of DC stimulation with CD40L. To examine the
effects of IL-12 in priming experiment 4, polyclonal neutralizing Abs to IL-12 ((R&D Systems) or normal goat IgG
(1 mg/ml), were added in the T cell/DC culture at initiation of priming.
Naïve CD8+ T cell priming
DC, prepared from HLA-A2+ cord blood (CB) MNC, were
activated overnight as described above, then pulsed with
10 mg/ml influenza matrix peptide Flu-MP (58–66
GILGFVTL; Genemed Synthesis, San Francisco, CA). Autologous purified T cells were obtained by negative selection, using mAbs specific for CD14 (3C10), CD40
(G28.5), CD32 (IV-3), CD11b (OKM1), glycophorin A
(10F7MN) (ATCC), and HLA-DP/DQ (SPVL-3) (kind gift
of Dr. H Yssel), followed by incubation with sheep antimouse magnetic beads (Dynal, Lake Success, NY). Cells
were further depleted with mAbs to HLA-DR and CD16
(Caltag) and a second round of selection with beads. The
resulting cell preparations contained > 95% CD3+ T cells.
Peptide pulsed-DC were irradiated (400-cGy 137Cs
source), washed twice, then incubated with purified T
cells in R10 medium supplemented with 10 ng/ml IL-7
(R&D Systems) at 37°C, 5% CO2. Cultures were replenished with R10 and IL-7 on day 3–4 by demi-depletion,
and were examined for the presence of antigen specific
cells by flow cytometry on day 7. Briefly, T cells were
counted then incubated in the dark at 37°C for 15 min.
with APC-labeled Flu-MP-HLA-A2 tetramer constructs
(NIAID Tetramer Facility and the NIH AIDS Research and
Reference Reagent Program, Atlanta, GA). After washing,
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cells were incubated with anti-CD8-FITC (OKT8, ATCC,
conjugated in our lab) and anti-CD45RA-PE (Caltag)
mAbs, then washed. Cells were resuspended with 5 mg/ml
propidium iodide (Sigma) for exclusion of dead cells and
analyzed by flow cytometry. The limit of detection of
CD8+ Flu-MP-HLA-A2 tetramer+ T cells was 0.02–0.04%
as determined by dilutions of a flu-MP specific HLA-A2+ T
cell line in HLA-A2- cord blood MNC. Negative control
consisted of HLA-A2- cord blood MNC in which < 0.01%
(n = 3) CD8+ Flu-MP-HLA-A2 tetramer+ cells were detected. Percent of CD8+ cells binding Flu-MP-HLA-A2 tetramer were calculated by setting quadrants based on staining
with isotype control Abs (staining <0.01%), and calculated as (% Flu-MP-HLA-A2 tetramer+ CD8+ cells) / (% total
CD8+ cells). Absolute number of tetramer+ cells was calculated as (% CD8+ Flu-MP-HLA-A2 tetramer+ cells) ´ (total number of cells in culture after priming). Fold
expansion specific T cells was calculated as (absolute
number of tetramer+ cells after priming) / (absolute
number of tetramer+ cells in initiating cultures).
Mixed lymphocyte reaction (MLR)
The procedure has been described elsewhere [14]. Briefly,
preparations >90% pure T cells were obtained from MNC
by removal of cells recognized by mAbs to CD14 (3C10),
CD40 (G28.5), CD32 (IV-3), CD11b (OKM1), glycophorin A (10F7MN), (ATCC, Manassas, VA) HLA-DP/DQ
(SPVL-3, kind gift of Dr. H Yssel) and CD16 (KD1, kind
gift of Dr. Ferlazzo, Istituto Nazionale per la Ricerca sul
Cancro, Genoa, Italy), HLA-DR and CD15 (Caltag) using
indirect panning on goat-anti-mouse IgG (Sigma)-coated
plates, followed by a second round of negative selection
with sheep anti-mouse magnetic beads (Dynal, Lake Success, NY). Populations of CD4+ or CD8+ T cells were obtained by removing the opposite subset in the second
round of purification. Allogeneic DC were irradiated and
cultured with pure T cells at the concentration of 20%
DC:T cell ratio in R10 medium for 8 days. On day 8, supernatant fluids were collected to measure cytokine content by ELISA and cells were harvested to be re-stimulated
for 5 hours on plates coated with mAbs to CD3 and CD28
(2 mg/ml each) (PharMingen, San Diego, CA). Monensin
(2 mM; Sigma) was added to enable the detection of intracellular IFN-g by flow cytometry.
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min 70°C). PCR products were separated on a 2% agarose
gel, stained with ethidium bromide.
Statistical analysis
Paired t-Test analysis was used to assess statistical differences where indicated.
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